04/10/2026
Derm Index: Breaking Down Cowden Syndrome
Cowden syndrome (CS), also known as multiple hamartoma syndrome, is a rare autosomal dominant disorder characterized by the presence of multiple benign tumor-like growths called hamartomas. These growths affect various tissues, including the skin, mucosa, bones, gastrointestinal tract, genitourinary system, eyes, and central nervous system (CNS). Cowden syndrome is also associated with an increased risk of several malignancies, particularly breast, thyroid, and endometrial cancers, which makes early detection critical for effective management.
The disorder is inherited equally among males and females, although the incidence of malignancies tends to differ by gender. The estimated prevalence of Cowden syndrome is approximately 1 in 250,000 individuals, with the onset of clinical manifestations occurring between birth and approximately 46 years of age.
Genetic Basis and Pathophysiology
The majority of Cowden syndrome cases result from mutations in the PTEN (phosphatase and tensin homolog) gene, a tumor suppressor gene that plays a key role in regulating cell growth, survival, and division. Mutations in PTEN lead to uncontrolled cell proliferation, which causes the formation of hamartomas and predisposes individuals to the development of malignancies, particularly in tissues such as the breast, thyroid, and uterus. Approximately 20% of patients with Cowden syndrome have no identifiable genetic mutation, suggesting that additional genetic or environmental factors may contribute to the disease in some individuals.
To Read More >>> https://oasisderm.com/cowden-syndrome-2/
Download the full PDF:https://oasisderm.com/wp-content/uploads/2024/12/Cowden-Syndrome.pdf
Image Source: dermnetnz.org
